Top 100 US Stocks — Best Combined Quality Score Across All Metrics on NYSE & NASDAQ

Each stock is scored on multiple quality dimensions: ROCE, ROE, revenue growth, EPS growth, balance sheet quality (low D/E), and valuation (low P/E). Each metric converts to a percentile score within the investment universe. Percentile scores are weighted and combined into a composite quality score. The 100 stocks with the highest composite scores represent the quality elite across all measured dimensions simultaneously.

Single-metric screens are vulnerable to sector anomalies, one-time events, and accounting differences. A composite across 6 independent dimensions is far more robust — statistically, a mediocre business cannot accidentally score above average on all 6 simultaneously. Multi-dimensional quality assessment has been shown in academic research to be more predictive of long-term returns than any single factor, including the well-studied value, momentum, and quality factors individually.

The core is relatively stable — businesses with genuinely superior multi-dimensional quality consistently score in the top tier. The periphery rotates as earnings are reported, sector conditions shift, and valuations move. Companies in the Top 100 in each of the last 8 consecutive quarters are the most reliable quality signals — consistent multi-period appearance confirms structural quality rather than a single-period metric spike.

The S&P 500 is market-cap weighted — the largest companies dominate regardless of quality metrics. The Top 100 is quality-score driven — the best multi-dimensional quality companies dominate regardless of size. The overlap is meaningful but incomplete. Some S&P 500 mega-caps are in the Top 100; many are not. Some mid-cap quality businesses appear in the Top 100 with much smaller S&P 500 weightings.

Technology software and semiconductor companies (high ROCE, ROE, and growth), healthcare specialty businesses (pricing power and margins), consumer staples brand leaders (consistent growth and returns), and payment network / exchange businesses (platform economics). Capital-intensive sectors — utilities, basic materials, energy — are typically underrepresented due to structurally lower ROCE and ROE relative to asset-light businesses.

It is an excellent quality research universe but not a simple buy-the-list strategy. The 100 stocks require individual valuation assessment — top-quality companies are often priced at premium multiples that reduce expected returns from current levels. An equal-weight or quality-weight approach to the Top 100 historically outperforms the S&P 500 on a risk-adjusted basis, but individual position sizing and entry price still matter for actual portfolio returns.

The list updates daily with price and earnings data changes. More significant changes occur quarterly as new earnings are reported — companies beating estimates improve their composite score; those missing estimates see their scores decline. The list is most active around earnings seasons (January, April, July, October). Daily monitoring is useful for active traders; quarterly review is sufficient for quality-focused long-term investors.

$500M minimum. This excludes micro-cap and very small-cap companies, which can show extreme single-metric scores (very high ROCE from minimal capital bases) without representing institutional-quality investment opportunities. The $500M threshold ensures the Top 100 consists of companies large enough for meaningful institutional investment and with broad enough analyst coverage to validate quality scores independently.

Use it as a quality validation layer. If a stock appears in the Top 100 AND on the Magic Formula screen, that's a strong combined quality-value signal. If a stock appears in the Top 100 AND near its 52-week low, that's a quality-contrarian opportunity. Cross-referencing the Top 100 with thematic screens — Technology High Growth, Dividend Growth — provides quality anchoring within specific thematic exposure.

Generally yes, but the score reflects historical metrics — past quality doesn't guarantee future quality. The #1 ranked stock may face competitive disruption the model doesn't capture. The composite score is a highly useful systematic filter for research prioritization, not a complete investment decision. Top-scored stocks deserve the first and deepest research attention; they are not automatically suitable for portfolio inclusion at any valuation.